http://www.hikma.com
Hikma Pharmaceuticals PLC Company Intro
Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment develops, manufactures, and sells generic injectable products primarily for use in hospitals. The Generics segment develops and manufactures oral and other non-injectable generic products for the retail market. The Branded segment develops, manufactures, markets, and sells branded generics and in-licensed products to retail and hospital markets. The company offers its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.
Industry
Healthcare
Hikma Pharmaceuticals PLC Headquaters
1 New Burlington Place
London,W1S 2HR
United Kingdom
Hikma Pharmaceuticals PLC Share price
17 May 2023 14:27 GMT
$1792.00
-43.5 (-2.37 %)
Hikma Pharmaceuticals PLC Market cap
$4.07 B
WMC RANKING
2024
Hikma Pharmaceuticals PLC # 10
Drug Manufacturers—Specialty & GenericLatest Hikma Pharmaceuticals PLC News
12 Feb 2024
Hikma Launches Combined Pain Relief Drug Combogesic IV In US
Hikma announced the launch of the pain relief solution in the US where it will be sold under the name Combogesic IV as part of a deal with Hyloris...
12 Feb 2024
Hikma Pharmaceuticals rises Monday, outperforms market
Hikma Pharmaceuticals PLC shares inched up 0.05% to £19.60 Monday, on what proved to be an all-around positive trading session for the stock market,...
13 Feb 2024
Global Oxytocin Market Poised for Remarkable Growth, Projected to Reach US$ 164.9 Million by 2030 | FMI analysis
The global oxytocin market is on track to witness substantial expansion, with a projected market value of US$ 164.9 million by the conclusion of 2030,...
WMC Market Score
WMC Market to Revenue Score
Hikma Pharmaceuticals PLC Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Hikma Pharmaceuticals PLC | USD | $2,341,000 | $641,000 | $431,000 | $40,700B | 10 |
| Teva Pharmaceutical Industries Limited | USD | $16,283,000 | $4,659,000 | $-3,982,000 | $91,050B | 1 |
| Bausch Health Companies Inc. | USD | $8,042,000 | $4,348,001 | $-1,018,000 | $21,900B | 2 |
| Zoetis Inc. | USD | $7,012,000 | $2,380,000 | $1,774,000 | $826,670B | 3 |
| Perrigo Company plc | USD | $4,990,000 | $1,357,500 | $-230,900 | $44,310B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Hikma Pharmaceuticals PLC Social Followers vs Top 4 Industry Competitors
Hikma Pharmaceuticals PLC Post vs Top 4 Industry Competitors
Hikma Pharmaceuticals PLC Digital Footprint By Size vs Top 4 Industry Competitors
Hikma Pharmaceuticals PLC Digital Footprint By Change Rate vs Top 4 Industry Competitors
Hikma Pharmaceuticals PLC WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Hikma Pharmaceuticals PLC | 14.38 | 0 | 0 | 0 | 0 | 0 | 0 |
| Teva Pharmaceutical Industries Limited | 100 | 3.55 | 2.31 | 55 | 0 | 0 | 20.74 |
| Bausch Health Companies Inc. | 49.39 | 1.02 | 47.07 | 91 | 0 | 0 | 47.76 |
| Zoetis Inc. | 43.06 | 100 | 100 | 92 | 0 | 0 | 100 |
| Perrigo Company plc | 30.65 | 4.61 | 3.01 | 100 | 0 | 0 | 36.89 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
